作者: M. Tanner , T. Teuscher , P.L. Alonso
DOI: 10.1016/0169-4758(95)80098-0
关键词:
摘要: Abstract A crucial step has been made in the development of malaria vaccines. The first trial SPf66 Africa and outside Latin America completed an area very intense perennial transmission. In this review, Marcel Tanner, Thomas Teuscher Pedro Alonso briefly discuss success limitations SPf66, questions which remain open prospects for further application.